Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Needham analyst Joseph Stringer upgraded the rating for Gilead Sciences, Inc. (NASDAQ:GILD) from Hold to Buy and announced a $133 price target. Gilead Sciences shares closed at $113.20 on Thursday. See how other analysts view this stock.
- Mizuho analyst Dan Dolev upgraded Global Payments Inc. (NYSE:GPN) from Neutral to …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Needham analyst Joseph Stringer upgraded the rating for Gilead Sciences, Inc. (NASDAQ:GILD) from Hold to Buy and announced a $133 price target. Gilead Sciences shares closed at $113.20 on Thursday. See how other analysts view this stock.
- Mizuho analyst Dan Dolev upgraded Global Payments Inc. (NYSE:GPN) from Neutral to …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Needham analyst Joseph Stringer upgraded the rating for Gilead Sciences, Inc. (NASDAQ:GILD) from Hold to Buy and announced a $133 price target. Gilead Sciences shares closed at $113.20 on Thursday. See how other analysts view this stock.
Mizuho analyst Dan Dolev upgraded Global Payments Inc. (NYSE:GPN) from Neutral to …Full story available on Benzinga.com Read MoreAPLD, CVNA, GILD, GPN, KMI, News, top upgrades, Upgrades, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, GILD, US3755581036, GPN, US37940X1028, KMI, US49456B1017, APLD, CVNA, News, Upgrades, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets
